Glasses or eye drops for slowing nearsightedness in kids
Treatments studied
Part of Eyes & vision clinical trials.
This study tests whether special glasses or low-dose atropine eye drops can slow down worsening nearsightedness in children. It compares four groups: glasses alone, eye drops alone, both together, or a placebo (no active treatment).
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 5 and 12 years old (not yet 12).
- They must have nearsightedness (myopia) of at least a certain amount, measured after special eye drops.
- They must be wearing glasses for at least 90% of waking hours for the past month.
- They cannot have used any previous treatments for nearsightedness, like special eye drops or contact lenses.
- You (the parent) must be willing to put artificial tear drops in your child's eyes every night for 2–4 weeks as a test run.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.
This study compares two ways to slow down worsening nearsightedness in children: special electronic glasses versus low-dose atropine eye drops. It may help your child keep their eyesight from getting much worse over time.
This study tests whether atropine eye drops can slow down worsening nearsightedness in children. It is for children whose nearsightedness is getting worse quickly and who have not tried other treatments.
This study tests whether a very low-dose atropine eye drop (0.01%) can safely slow down worsening nearsightedness in children. It is for kids ages 3 to 12 who are already nearsighted but haven't used other myopia control treatments before.
This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.
This trial tests whether a combination of low-dose atropine eye drops (0.02% or 0.04%) and special glasses (called DIMS) can slow down the worsening of moderate to high myopia in children aged 6 to 12.
Hear when a new Myopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.